Albumin binding function is a novel biomarker for early liver damage and disease progression in non-alcoholic fatty liver disease
ConclusionOur findings suggest albumin binding function is a novel biomarker for early liver damage and disease progression in NAFLD.
Source: Endocrine - Category: Endocrinology Source Type: research
More News: Alcoholism | Cirrhosis | Endocrinology | Fatty Liver Disease (FLD) | Hepatitis | Liver | Liver Disease | Non-alcoholic Fatty Liver Diseases (NAFLD) | Study | Urology & Nephrology